Francois Rochon's NVO Position Overview
Francois Rochon (via Giverny Capital Inc.) currently holds 12.4K shares of Novo Nordisk A/S (NVO) worth $688,076, representing 0.02% of the portfolio. First purchased in 2020-Q3, this long-term strategic position has been held for 21 quarters.
Based on 13F filings, Francois Rochon has maintained a strategic position in NVO, demonstrating sustained confidence in this investment.
Analysis based on 13F filings available since 2013 Q2
Francois Rochon's Novo Nordisk A/S (NVO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Novo Nordisk A/S (NVO) Trades by Francois Rochon
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2020 | +12,400 | New Buy | 12,400 | $34.68 |
Francois Rochon's Novo Nordisk A/S Investment FAQs
Francois Rochon first purchased Novo Nordisk A/S (NVO) in Q3 2020, acquiring 12,400 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Francois Rochon has held Novo Nordisk A/S (NVO) for 21 quarters since Q3 2020. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Francois Rochon's largest addition to Novo Nordisk A/S (NVO) was in Q3 2020, adding 12,400 shares worth $430,000. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Francois Rochon's firm, Giverny Capital Inc., owns 12,400 shares of Novo Nordisk A/S (NVO), valued at approximately $688,076. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Novo Nordisk A/S (NVO) represents approximately 0.02% of Francois Rochon's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Francois Rochon's peak holding in Novo Nordisk A/S (NVO) was 12,400 shares, as reported at the end of Q3 2020. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.